Rights and permissions
About this article
Cite this article
Infliximab worth it for Crohn's disease in the UK. Inpharma Wkly. 1515, 4 (2005). https://doi.org/10.2165/00128413-200515150-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515150-00006